Targeting the prostate cancer stem cell niche with the STAT3 inhibitor galiellalactone.

被引：0
|
作者：
Canesin, Giacomo [1 ]
Collins, Anne T. [2 ]
Hellsten, Rebecka [1 ]
Maitland, Norman J. [2 ]
Bjartell, Anders [1 ]
机构：
[1] Lund Univ, Malmo, Sweden
[2] Univ York, York, N Yorkshire, England
来源：
CANCER RESEARCH | 2018年 / 78卷 / 16期
关键词：
D O I：
10.1158/1538-7445.PRCA2017-A040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A040
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [1] Targeting STAT3 in prostate cancer: Identification of STAT3 as a direct target of the fungal metabolite galiellalactone.
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    Hellsten, Rebecka
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [2] Targeting STAT3 in castration-resistant prostate cancer: Galiellalactone as a direct inhibitor of STAT3 in prostate cancer cells.
    Hellsten, Rebecka
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin Hans
    Kjellstrom, Sven
    Garcia, Victor
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin
    Kjellstrom, Sven
    Garcia, Victor
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    Hellsten, Rebecka
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (23) : 15969 - 15978
  • [4] STAT3 inhibition with Galiellalactone effectively targets the prostate cancer stem-like cell population
    Canesin, Giacomo
    Collins, Anne T.
    Hellsten, Rebecka
    Maitland, Norman J.
    Bjartell, Anders
    [J]. CANCER RESEARCH, 2017, 77
  • [5] STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
    Canesin, Giacomo
    Maggio, Valentina
    Palominos, Macarena
    Stiehm, Anna
    Contreras, Hector R.
    Castellon, Enrique A.
    Morote, Juan
    Paciucci, Rosanna
    Maitland, Norman J.
    Bjartell, Anders
    Hellsten, Rebecka
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
    Giacomo Canesin
    Valentina Maggio
    Macarena Palominos
    Anna Stiehm
    Hector R. Contreras
    Enrique A. Castellón
    Juan Morote
    Rosanna Paciucci
    Norman J. Maitland
    Anders Bjartell
    Rebecka Hellsten
    [J]. Scientific Reports, 10
  • [7] Galiellalactone derivative targets stem cell population in ENZ-resistant prostate cancer through inhibition of STAT3
    Vahid, Sepideh
    Thaper, Daksh
    Davies, Alistair
    Van Rensburg, Micaela Janse
    Gibson, Kate
    Ketola, Krisi
    Johansson, Martin
    Bishop, Jennifer L.
    Zoubeidi, Amina
    [J]. CANCER RESEARCH, 2016, 76
  • [8] Prostate cancer cell induced generation of myeloid derived suppressor cells from monocytes ex vivo is inhibited by targeting STAT3 with galiellalactone
    Helisten, R.
    Leandersson, K.
    Johansson, M.
    Bjartell, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 69 : S57 - S57
  • [9] Galiellalactone inhibits growth of prostate cancer cell xenografts and induces apoptosis of human prostate cancer cells expressing active Stat3
    Hellsten, R.
    Johansson, M.
    Sterner, O.
    Bjartell, A.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (14) : 797 - 797
  • [10] The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer
    Canesin, Giacomo
    Evans-Axelsson, Susan
    Hellsten, Rebecka
    Sterner, Olov
    Krzyzanowska, Agnieszka
    Andersson, Tommy
    Bjartell, Anders
    [J]. EUROPEAN UROLOGY, 2016, 69 (03) : 400 - 404
12345